Literature DB >> 15408422

Progress in the treatment of typhoid fever with Vi bacteriophages.

J M DESRANLEAU.   

Abstract

Entities:  

Keywords:  BACTERIOPHAGE; TYPHOID

Mesh:

Year:  1949        PMID: 15408422

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


× No keyword cloud information.
  11 in total

1.  A conserved acetyl esterase domain targets diverse bacteriophages to the Vi capsular receptor of Salmonella enterica serovar Typhi.

Authors:  Derek Pickard; Ana Luisa Toribio; Nicola K Petty; Andries van Tonder; Lu Yu; David Goulding; Bart Barrell; Richard Rance; David Harris; Michael Wetter; John Wain; Jyoti Choudhary; Nicholas Thomson; Gordon Dougan
Journal:  J Bacteriol       Date:  2010-09-03       Impact factor: 3.490

2.  Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West.

Authors:  Dottore Emiliano Fruciano; Shawna Bourne
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-01       Impact factor: 2.471

3.  Results obtained with a glycerolated Vi antigen in the detection of chronic typhoid carriers.

Authors:  M SAINT-MARTIN; J M DESRANLEAU
Journal:  Am J Public Health Nations Health       Date:  1951-06

4.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

5.  A genomewide mutagenesis screen identifies multiple genes contributing to Vi capsular expression in Salmonella enterica serovar Typhi.

Authors:  Derek Pickard; Robert A Kingsley; Christine Hale; Keith Turner; Karthikeyan Sivaraman; Michael Wetter; Gemma Langridge; Gordon Dougan
Journal:  J Bacteriol       Date:  2013-01-11       Impact factor: 3.490

6.  Molecular characterization of the viaB locus encoding the biosynthetic machinery for Vi capsule formation in Salmonella Typhi.

Authors:  Michael Wetter; David Goulding; Derek Pickard; Michael Kowarik; Charles J Waechter; Gordon Dougan; Michael Wacker
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

7.  Characterization of a ViI-like phage specific to Escherichia coli O157:H7.

Authors:  Elizabeth M Kutter; Kyobi Skutt-Kakaria; Bob Blasdel; Ayman El-Shibiny; Anna Castano; Daniel Bryan; Andrew M Kropinski; Andre Villegas; Hans-Wolfgang Ackermann; Ana L Toribio; Derek Pickard; Hany Anany; Todd Callaway; Andrew D Brabban
Journal:  Virol J       Date:  2011-09-07       Impact factor: 4.099

8.  Enhancing and initiating phage-based therapies.

Authors:  Philip Serwer; Elena T Wright; Juan T Chang; Xiangan Liu
Journal:  Bacteriophage       Date:  2014-12-15

Review 9.  In-Gel Isolation and Characterization of Large (and Other) Phages.

Authors:  Philip Serwer; Elena T Wright
Journal:  Viruses       Date:  2020-04-07       Impact factor: 5.048

Review 10.  Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design.

Authors:  Yi-An Yang; Alexander Chong; Jeongmin Song
Journal:  Vaccines (Basel)       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.